The TROG Cancer Research QA team actively supports clinical trial activities through:
The TROG QA team works with each trial chair, physicist, radiation therapist and the Trial Management Committee (TMC) to formulate the clinical trial QA program.
TROG Cancer Research employs a risk-based approach when developing a trial radiation therapy and imaging QA program to identify risks that could affect the trial outcome. These risks are analysed in terms of the likelihood of occurrence and the severity of impact on the trial question.
There are several radiation therapy and imaging QA interventions that may be recommended for a particular study, including pre-trial credentialing, benchmarking, dosimetric auditing requirements, imaging collection and on-trial case reviews
A QA program is typically developed in four stages and requires input from various professionals and committees.
Contact us
If you require any further information or want to discuss collaborating with TROG, don’t hesitate to contact us at: qa@trog.com.au
Have your say – provide feedback today
The TROG QA team are always seeking to improve processes and systems. We value positive and constructive feedback from our members and clinical trials colleagues.
If you have any feedback or suggestions relevant to TROG QA, please feel free to complete our feedback survey or contact us.
